Skip to content

Clinical trials

Phase 3 Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 3 Country / region: United States Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20013
20023
20038
20045
20052
20064
20074
20085
20091
20101
20113
20123
20133
20143
20152
20161
20183
20192
20203
20212
20222
20232
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated13
Active, not recruiting8
Recruiting5
Unknown status4
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center8
Children's Oncology Group7
Alliance for Clinical Trials in Oncology5
SWOG Cancer Research Network5
Jonsson Comprehensive Cancer Center4
Medical College of Wisconsin4
Eastern Cooperative Oncology Group3
Memorial Sloan Kettering Cancer Center3
Pfizer3
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma102
Lymphoma, Non-Hodgkin46
Lymphoma, Large B-Cell, Diffuse40
Leukemia38
Lymphoma, Follicular35
Precursor Cell Lymphoblastic Leukemia-Lymphoma28
Hodgkin Disease27
Leukemia, Lymphocytic, Chronic, B-Cell27
Burkitt Lymphoma26
Lymphoma, B-Cell, Marginal Zone23

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.